Management of perforations during endoscopic resection.


Journal

Best practice & research. Clinical gastroenterology
ISSN: 1532-1916
Titre abrégé: Best Pract Res Clin Gastroenterol
Pays: Netherlands
ID NLM: 101120605

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 09 12 2023
revised: 02 02 2024
accepted: 25 02 2024
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 15 5 2024
Statut: ppublish

Résumé

Despite the evolution in tools and techniques, perforation is still one of the most pernicious adverse events of therapeutic endoscopy with potentially huge consequences. As advanced endoscopic resection techniques are worldwide spreading, endoscopists must be ready to manage intraprocedural perforations. In fact, immediate endoscopic closure through a prompt diagnosis represents the first-line option, saving patients from surgery, long hospitalizations and worse outcomes. Traditional and novel endoscopic closure modalities, including clips, suturing devices, stents and vacuum therapy, are increasingly expanding the therapeutic armamentarium for closing these defects. Nevertheless, available literature on this topic is currently limited. In this review our goal is to give an overview on the management of perforations occurring during endoscopic resections, with particular attention to characteristics, advantages, disadvantages and new horizons of endoscopic closure tools.

Identifiants

pubmed: 38749581
pii: S1521-6918(24)00019-2
doi: 10.1016/j.bpg.2024.101900
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101900

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Cesare Hassan:Fujifilm Co. (consultancy); Medtronic Co. (consultancy), Alessandro Repici: Fujifilm Co. (consultancy); Olympus Corp (consultancy); Medtronic Co. (consultancy); Roberta Maselli: Fujifilm Co. (speaking honorarium). Other authors have no conflict of interest to disclose.

Auteurs

Ludovico Alfarone (L)

Humanitas Clinical and Research Center, IRCCS-, Endoscopy Unit, Rozzano, Italy.

Marco Spadaccini (M)

Humanitas Clinical and Research Center, IRCCS-, Endoscopy Unit, Rozzano, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy. Electronic address: marco.spadaccini@humanitas.it.

Alessandro Repici (A)

Humanitas Clinical and Research Center, IRCCS-, Endoscopy Unit, Rozzano, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy.

Cesare Hassan (C)

Humanitas Clinical and Research Center, IRCCS-, Endoscopy Unit, Rozzano, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy.

Roberta Maselli (R)

Humanitas Clinical and Research Center, IRCCS-, Endoscopy Unit, Rozzano, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH